{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:23:29Z","timestamp":1786987409343,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.contraception.2025.110860","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T02:50:57Z","timestamp":1740538257000},"page":"110860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Contraception and nonalcoholic fatty liver disease in women with prior gestational diabetes mellitus"],"prefix":"10.1016","volume":"145","author":[{"given":"Supatsri","family":"Sethasine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasiwan","family":"Suthasmalee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siriwan","family":"Tangjitgamol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0925-2613","authenticated-orcid":false,"given":"Chadakarn","family":"Phaloprakarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.contraception.2025.110860_bib1","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1001\/jama.2021.21392","article-title":"Contraception selection, effectiveness, and adverse effects: a review","volume":"326","author":"Teal","year":"2021","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.contraception.2025.110860_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7304a1","article-title":"U.S. Medical eligibility criteria for contraceptive use, 2024","volume":"73","author":"Nguyen","year":"2024","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"10.1016\/j.contraception.2025.110860_bib3","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/ajo.12973","article-title":"Factors predicting recurrence of gestational diabetes in a high-risk multi-ethnic population","volume":"59","author":"Wong","year":"2019","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.contraception.2025.110860_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12884-021-04352-w","article-title":"Glucose levels during gestational diabetes pregnancy and the risk of developing postpartum diabetes or prediabetes","volume":"22","author":"Phaloprakarn","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"issue":"10","key":"10.1016\/j.contraception.2025.110860_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2019.06.006","article-title":"Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus: a population-based cohort study, systematic review and meta-analysis","volume":"33","author":"Lavrentaki","year":"2019","journal-title":"J Diabetes Complications"},{"issue":"1","key":"10.1016\/j.contraception.2025.110860_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2337\/dc21-1018","article-title":"Gestational diabetes mellitus and the risks of overall and type-specific cardiovascular diseases: a population- and sibling-matched cohort study","volume":"45","author":"Yu","year":"2022","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.contraception.2025.110860_bib7","doi-asserted-by":"crossref","first-page":"S282","DOI":"10.2337\/dc24-S015","article-title":"Management of diabetes in pregnancy: standards of care in diabetes-2024","volume":"47","author":"American Diabetes Association Professional Practice Committee. 15","year":"2024","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.contraception.2025.110860_bib8","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1530\/EC-20-0423","article-title":"Effects of oral contraceptives on metabolic parameters in adult premenopausal women: a meta-analysis","volume":"9","author":"Silva-Bermudez","year":"2020","journal-title":"Endocr Connect"},{"issue":"1","key":"10.1016\/j.contraception.2025.110860_bib9","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1186\/s12905-023-02703-7","article-title":"Association between oral contraceptives with lipid profile: results from Hoveyzeh cohort study (HCS)","volume":"23","author":"Hashemi","year":"2023","journal-title":"BMC Womens Health"},{"issue":"1","key":"10.1016\/j.contraception.2025.110860_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12978-023-01727-4","article-title":"Effects of hormonal contraceptives on lipid profile among women attending family planning unit in Goba Town Public Health Facilities, Bale, Southeast Ethiopia: a comparative cross-sectional study","volume":"20","author":"Turki","year":"2023","journal-title":"Reprod Health"},{"issue":"6","key":"10.1016\/j.contraception.2025.110860_bib11","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.cgh.2020.08.012","article-title":"Associations between reproductive and hormone-related factors and risk of nonalcoholic fatty liver disease in a multiethnic population","volume":"19","author":"Wang","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.contraception.2025.110860_bib12","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00535-012-0715-8","article-title":"Oral contraceptive pill use is associated with reduced odds of nonalcoholic fatty liver disease in menstruating women: results from NHANES III","volume":"48","author":"Liu","year":"2013","journal-title":"J Gastroenterol"},{"issue":"1","key":"10.1016\/j.contraception.2025.110860_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13006-024-00632-1","article-title":"Lactation duration and development of type 2 diabetes and metabolic syndrome in postpartum women with recent gestational diabetes mellitus","volume":"19","author":"Suthasmalee","year":"2024","journal-title":"Int Breastfeed J"},{"issue":"1","key":"10.1016\/j.contraception.2025.110860_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12978-024-01783-4","article-title":"Impact of postpartum weight change on metabolic syndrome and its components among women with recent gestational diabetes mellitus","volume":"21","author":"Phaloprakarn","year":"2024","journal-title":"Reprod Health"},{"issue":"1","key":"10.1016\/j.contraception.2025.110860_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13006-024-00684-3","article-title":"Relationship between breastfeeding and hepatic steatosis in women with previous gestational diabetes mellitus","volume":"19","author":"Sethasine","year":"2024","journal-title":"Int Breastfeed J"},{"issue":"5","key":"10.1016\/j.contraception.2025.110860_bib16","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/jdi.13411","article-title":"Prevalence of non-alcoholic fatty liver disease and factors associated with it in Indian women with a history of gestational diabetes mellitus","volume":"12","author":"Kubihal","year":"2021","journal-title":"J Diabetes Investig"},{"issue":"6","key":"10.1016\/j.contraception.2025.110860_bib17","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.contraception.2025.110860_bib18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.contraception.2013.03.004","article-title":"Weight change at 12 months in users of three progestin-only contraceptive methods","volume":"88","author":"Vickery","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110860_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100800","article-title":"Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: findings from a randomised, multicentre, open-label trial","volume":"34","author":"Beksinska","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"8","key":"10.1016\/j.contraception.2025.110860_bib20","article-title":"Progestin-only contraceptives: effects on weight","volume":"2016","author":"Lopez","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.contraception.2025.110860_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33419-6","article-title":"Association between body mass index and fatty liver risk: a dose-response analysis","volume":"8","author":"Fan","year":"2018","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.contraception.2025.110860_bib22","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3892\/br.2014.309","article-title":"Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes","volume":"2","author":"Tomizawa","year":"2014","journal-title":"Biomed Rep"},{"issue":"1","key":"10.1016\/j.contraception.2025.110860_bib23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12905-024-02990-8","article-title":"Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial","volume":"24","author":"Hofmeyr","year":"2024","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.contraception.2025.110860_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fgwh.2022.887541","article-title":"Effects of depot medroxyprogesterone acetate intramuscular injection, copper intrauterine device and levonorgestrel implant contraception on estradiol levels: an ancillary study of the ECHO randomized trial","volume":"3","author":"Ryan","year":"2022","journal-title":"Front Glob Womens Health"},{"issue":"6","key":"10.1016\/j.contraception.2025.110860_bib25","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3390\/genes13060966","article-title":"Associations of sex steroids and sex hormone-binding globulin with non-alcoholic fatty liver disease: a population-based study and meta-analysis","volume":"13","author":"Zhang","year":"2022","journal-title":"Genes (Basel)"},{"issue":"6","key":"10.1016\/j.contraception.2025.110860_bib26","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/ijo.2017.50","article-title":"Hormone signaling and fatty liver in females: analysis of estrogen receptor \u03b1 mutant mice","volume":"41","author":"Hart-Unger","year":"2017","journal-title":"Int J Obes (Lond)"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425000514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425000514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T21:12:25Z","timestamp":1762117945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782425000514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":26,"alternative-id":["S0010782425000514"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2025.110860","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contraception and nonalcoholic fatty liver disease in women with prior gestational diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2025.110860","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110860"}}